Botanix Pharmaceuticals Limited
BXPHF
$0.099
-$0.001-1.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -542.17% | -530.15% | -464.91% | -478.11% | -81.91% |
| Total Depreciation and Amortization | 1,639.34% | 1,603.32% | 13,392.59% | 13,278.57% | -32.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 671.09% | 656.63% | -146.59% | -147.69% | -0.48% |
| Change in Net Operating Assets | -1,633.68% | -1,605.10% | -- | -- | 127.68% |
| Cash from Operations | -969.00% | -949.01% | -712.66% | -731.68% | 32.09% |
| Capital Expenditure | -148.81% | -143.65% | -150.00% | -156.78% | -2,700.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 100.00% | 94.82% | 94.70% | -60.15% |
| Cash from Investing | 94.10% | 94.21% | 94.22% | 94.09% | -63.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -44.84% | -44.84% | -98.37% | -98.37% | 615.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 20.82% | 20.82% | -- | -- | -580.05% |
| Cash from Financing | -7.60% | -9.33% | -98.50% | -98.47% | 610.95% |
| Foreign Exchange rate Adjustments | -182.73% | -181.09% | 190.89% | 193.05% | -28.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.66% | -74.15% | -482.83% | -491.78% | 3,820.64% |